Shan Lu - Publications

Amorphous/crystalline-RuCoNiP/NF achieves efficient alkaline hydrogen evolution in multiple freshwater and seawater scenarios.

Journal: Journal of colloid and interface science

Published: July 20, 2025

Combination therapy and drug co-delivery systems for atherosclerosis.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 13, 2024

Circadian rhythm gene cryptochrome 2 (Cry2) interacts with lipid metabolism to promote vascular aging.

Journal: Archives of gerontology and geriatrics

Published: October 16, 2024

Navigating the landscape: Prospects and hurdles in targeting vascular smooth muscle cells for atherosclerosis diagnosis and therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 21, 2023

Investigation of the applicability of the zebrafish model for the evaluation of aristolochic acid-related nephrotoxicity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 28, 2023

Improving physicochemical properties and pharmacological activities of ternary co-amorphous systems.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: May 16, 2022

A new prediction method for sodium aluminate solution evaporation integrating process knowledge and data-driven spatial-temporal adaptive model.

Journal: ISA transactions

Published: April 25, 2022

Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.

Journal: Journal of pharmaceutical sciences

Published: December 28, 2021

Protective Effect of Ginsenoside Rb1 Nanoparticles Against Contrast-Induced Nephropathy by Inhibiting High Mobility Group Box 1 Gene/Toll-Like Receptor 4/NF-κB Signaling Pathway.

Journal: Journal of biomedical nanotechnology

Published: October 28, 2021

Design and molecular insights of drug-active metabolite based co-amorphous formulation: A case study of toltrazuril-ponazuril co-amorphous.

Journal: International journal of pharmaceutics

Published: October 25, 2021

Fabrication of Stable Apigenin Nanosuspension with PEG 400 as Antisolvent for Enhancing the Solubility and Bioavailability.

Journal: AAPS PharmSciTech

Published: July 08, 2021

Apigenin-oxymatrine binary co-amorphous mixture: Enhanced solubility, bioavailability, and anti-inflammatory effect.

Journal: Food chemistry

Published: May 08, 2021